NorthShore University HealthSystem | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy	Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, Ehlers-Danlos syndrome, Fatigue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, narcolepsy, nervous system disorder, psychiatric disorder, sleep-wake disorder	Recruiting	Phase 3	2026-08-27		NCT07675135
The PATHway Study: Primary Care Based Depression Prevention in Adolescents	depressive disorder	Active, not recruiting	Not applicable	2026-06-22		NCT05203198
A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy	Multifocal Motor Neuropathy (MMN)	Active, not recruiting	Phase 2	2026-03-11		NCT05405361
Understanding the Long-term Impact of COVID on Children and Families	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Not stated	2025-12-31		NCT05172011
Effects of TNF Blockade on Human BPH/LUTS	Genital Diseases, Male Urogenital Diseases, Urogenital Diseases, benign prostatic hyperplasia, male reproductive system disorder, prostate disorder	Recruiting	Phase 2	2024-11-21		NCT06062875
Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Fuchs' endothelial dystrophy, corneal disorder, corneal dystrophy, eye disorder, hereditary disease	Recruiting	Phase 4	2021-08-11		NCT03249337